Pre-clinical efficacy and safety evaluation of MOv18 IgE, a novel class of antibody targeting alpha folate receptor

Project: Research

Project Details

StatusFinished
Effective start/end date1/11/200930/06/2012

Collaborative partners

Funding

  • CRUK Cancer Research UK: £106,823.00
  • CRUK Cancer Research UK: £102,714.00